AI early warning system for brain surgery risk
Part of Brain & nervous system clinical trials.
This study uses artificial intelligence (AI) to create an early warning system that watches for complications during and after brain surgery for hemorrhagic stroke (bleeding in the brain). The goal is to help doctors catch problems sooner, which could improve your recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old
- You have a brain scan (CT or MRI) showing one of these: an aneurysm, an AVM, hemorrhagic moyamoya disease, a cavernous malformation, or a bleed inside the brain
- You are having surgery within 7 days of your symptoms starting
- You agree to take part and give written permission (informed consent)
- You are not already enrolled in another research study that would conflict with this one
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares a new AI-guided procedure to remove blood clots from the brain with standard medical treatment. It may help people who had a stroke from high blood pressure and have a medium-sized bleed in the upper part of the brain.
This study tests an artificial intelligence system that watches for early signs of complications after a heart attack. If you join, the system may help doctors catch problems sooner.
This study tests an artificial intelligence system designed to help doctors make better treatment decisions for patients with sudden brain bleeding. The AI analyzes CT scans and patient information to guide care choices during hospitalization.
This study uses artificial intelligence (machine learning) and blood tests to find early signs of delayed brain injury after a brain bleed. It aims to help doctors detect and treat this complication sooner.
This trial uses an AI-assisted ultrasound to quickly detect brain bleeding in people with acute stroke. It may help speed up diagnosis and treatment.
This trial tests a minimally invasive surgery guided by artificial intelligence to treat spontaneous brain bleeding. It aims to improve recovery by precisely removing the clot with less damage to healthy brain tissue.
Hear when a new Acute Hemorrhagic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.